SGNLVA-001: A phase 1 open-label dose escalation and expansion study of SGN-LIV1A administered weekly in breast cancer Meeting Abstract
| Authors: | Beckwith, H. C.; Medgyesy, D. C.; Abraham, J.; Nanda, R.; Tkaczuk, K. H. R.; Krop, I. E.; Pusztai, L.; Modi, S.; Mita, M. M.; Specht, J. M.; Hurvitz, S. A.; Han, H. S.; Kalinsky, K.; Wilks, S.; O'Shaughnessy, J.; Hart, L. L.; Rugo, H. S.; Mitri, Z. I.; Garfin, P. M.; Burris, H. A. 3rd |
| Abstract Title: | SGNLVA-001: A phase 1 open-label dose escalation and expansion study of SGN-LIV1A administered weekly in breast cancer |
| Meeting Title: | 43rd Annual San Antonio Breast Cancer Symposium (2020 SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 81 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2020 Dec 8-11 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2021-02-01 |
| Language: | English |
| ACCESSION: | WOS:000618737700037 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.SABCS20-OT-03-03 |
| Notes: | Meeting Abstract: OT-03-03 -- This symposium was held virtually due to COVID-19 -- Source: Wos |
